Culture

Counterintuitive approach may improve eyewitness identification

Experts have devised a novel approach to selecting photos for police lineups that helps witnesses identify culprits more reliably.

In a paper published by the Proceedings of the National Academy of Sciences, researchers - from the University of California San Diego and Duke University in the United States and the University of Birmingham in the U.K. - show for the first time that selecting fillers who match a basic description of the suspect but whose faces are less similar, rather than more, leads to better outcomes than traditional approaches in the field.

The counterintuitive technique improves eyewitness performance by about 10 percent.

"In practice, police tend to err on the side of picking facially similar fillers for their lineups," said John Wixted, the paper's senior author and a professor in the UC San Diego Department of Psychology. "What our study shows is that it is, contrary to intuition, actually better to pick fillers who are facially dissimilar. Doing it this way continues to protect the innocent to the same degree while helping witnesses to correctly identify the guilty more frequently."

In a study of 19,732 participants, the researchers played a mock-crime video depicting a white male stealing an office laptop and then provided photographs of one suspect (either the perpetrator or an innocent suspect) plus five police lineup fillers. The fillers always matched the most basic description of the perpetrator but they varied in how much they facially resembled him. Facial similarity among photos was scored by an additional set of participants on a scale of 1 to 7, with 7 being most similar.

The researchers found that picking fillers who were facially dissimilar enhanced the ability of eyewitnesses to accurately pick out the perpetrator when he was in the lineup, without increasing the likelihood of wrongly identifying an innocent suspect when the real perpetrator was not in the lineup.

In a typical police lineup, one photo of the suspect is displayed, plus photos of five or more "fillers" who are known to be innocent. To create a fair lineup in which the suspect does not stand out, fillers are selected if they are similar in basic appearance to the suspect (height, weight, race, hair color and length, etc.), or if they have facial features included in a witness's description of the culprit. Often, a combined approach is used, in which fillers with similar facial features are selected from a pool of description-matched photos.

For decades, experts have disagreed on and puzzled over the question of what is most effective, while also being fair to the suspect. There are concerns that using fillers that are too facially similar to the suspect will confuse eyewitnesses and protect guilty suspects by making the identification task too difficult. Conversely, if the fillers are too facially dissimilar to the suspect, there are concerns that this would put an innocent suspect at risk of being falsely identified.

The new approach relied on insights from signal detection theory - which considers the memory strengths that are generated by each face in the lineup in the mind of the eyewitness - to deduce that selecting fillers who are not facially similar to the suspect from a pool of acceptable description-matched photos actually increases the ability of eyewitnesses to discriminate between innocent and guilty suspects.

Importantly, this approach did not have any effect on the number of "false alarms," in which an innocent suspect is incorrectly identified.

Credit: 
University of California - San Diego

New immunotherapy target discovered for malignant brain tumors

image: Kai Wucherpfennig, MD, PhD, Dana-Farber Cancer Institute

Image: 
Dana-Farber Cancer Institute

Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body's immune system. The discovery, reported in the journal CELL, emerged from laboratory experiments and has no immediate implications for treating patients.

Scientists from Dana-Farber Cancer Institute, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard said the target they identified is a molecule that suppresses the cancer-fighting activity of immune T cells, the white blood cells that seek out and destroy virus-infected cells and tumor cells.

The scientists said the molecule, called CD161, is an inhibitory receptor that they found on T cells isolated from fresh samples of brain tumors called diffuse gliomas. Gliomas include glioblastoma, the most aggressive and incurable type of brain tumor. The CD161 receptor is activated by a molecule called CLEC2D on tumor cells and immune-suppressing cells in the brain, according to the researchers. Activation of CD161 weakens the T cell response against tumor cells.

To determine if blocking the CD161 pathway could restore the T cells' ability to attack the glioma cells, the researchers disabled it in two ways: they knocked out the gene called KLRB1 that codes for CD161, and they used antibodies to block the CD161-CLEC2D pathway. In an animal model of gliomas, this strategy strongly enhanced the killing of tumor cells by T cells, and improved survival of the animals. The researchers were also encouraged because blocking the inhibitory pathway appeared to reduce T-cell exhaustion - a loss of cell-killing function in T cells that has been a been a major hurdle in immunotherapy.

In addition, "we showed that this pathway is also relevant in a number of other major human cancer types," including melanoma, lung, colon, and liver cancer, said Kai Wucherpfennig, MD, PhD, director of the Center for Cancer Immunotherapy Research at Dana-Farber. He is corresponding author of the report along with Mario Suva, MD, PhD, of Massachusetts General Hospital; Aviv Regev, PhD, of the Broad Institute, and David Reardon, MD, clinical director of the Center for Neuro-Oncology at Dana-Farber.

Many cancer patients are now being treated with immunotherapy drugs that disable "immune checkpoints" - molecular brakes exploited by cancer cells to suppress the body's defensive response by T cells against tumors. Disabling these checkpoints unleashes the immune system to attack cancer cells. One of the most frequently targeted checkpoints is PD-1. However, recent trials of drugs that target PD-1 in glioblastomas have failed to benefit patients. In the current study, the researchers found that fewer T cells from gliomas contained PD-1 than CD161. As a result, they said, "CD161 may represent an attractive target, as it is a cell surface molecule expressed by both CD8 and CD4 T cell subsets [the two types of T cells involved in response against tumor cells] and a larger fraction of T cells express CD161 than the PD-1 protein."

Prior to the current study, the researchers said little was known about the expression of genes and the molecular circuits of immune T cells that infiltrate glioma tumors, but fail to halt their growth. To open a window on these T cell circuits, the investigators took advantage of new technologies for reading out the genetic information in single cells - a method called single-cell RNA-seq. They applied RNA-seq to glioma-infiltrating T cells from fresh tumor samples from 31 patients and created an "atlas" of pathways that regulate T cell function. In analyzing the RNA-seq data, the researchers identified the CD161 protein, encoded by the KLRB1 gene, as a potential inhibitory receptor. They then used CRISPR/Cas9 gene-editing technology to inactivate the KLRB1 gene in T cells and showed that CD161 inhibits the tumor cell-killing function of T cells.

"Our comprehensive atlas of T cell expression programs across the major classes of diffuse gliomas thus identifies the CD161-CLEC2D pathway as a potential target for immunotherapy of diffuse gliomas and other human cancers," the authors of the report said.

This strategy was tested in two different animal models created by implanting "gliomaspheres" - 3-dimensional clusters of tumor cells from human patients - into rodents, which developed aggressive tumors that invaded the brain. The scientists subsequently injected T cells with the KLRB1 gene edited out into the cerebrospinal fluid of some of the animals, and T cells that hadn't had the KLRB1 gene deleted. Transfer of the gene-edited T cells slowed the growth of the tumors and "conferred a significant survival benefit," in both of the animal models of gliomas, the scientists said.

Credit: 
Dana-Farber Cancer Institute

Mid-life cardiovascular disease prevention may protect against later dementia

Employing cardiovascular disease prevention strategies in mid-life may delay or stop the brain alterations that can lead to dementia later in life, according to a study in the Journal of the American College of Cardiology.

Atherosclerosis, or buildup of fats, cholesterol and other substances in and on artery walls, is the underlying cause of most cardiovascular diseases, which is the leading cause of death around the world. Dementia is also among the top causes of death and disability around the world, with 50 million people currently living with dementia. The presence of atherosclerosis has been linked to cognitive impairment in advanced stages of the disease, but little is known about how they influence each other, especially since both can be asymptomatic for long periods of time earlier in life.

Using 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) scans of 547 participants from the Progression of Early Subclinical Atherosclerosis study, researchers sought to determine the association between brain metabolism, subclinical atherosclerosis and cardiovascular risk factors in asymptomatic, middle-aged adults. They found that cardiovascular risk is associated with brain hypometabolism, including the cerebral areas known to be affected in dementia. Hypertension was the modifiable cardiovascular disease risk factor with the strongest association.

According to researchers, these results underscore the need to control cardiovascular disease risk factors early in life to potentially reduce the brain's later vulnerability to cognitive dysfunction.

Credit: 
American College of Cardiology

New skin patch brings us closer to wearable, all-in-one health monitor

image: This soft, stretchy patch can monitor the wearer's blood pressure and biochemical levels at the same time.

Image: 
Wang lab/UC San Diego

Engineers at the University of California San Diego have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer's levels of glucose as well as lactate, alcohol or caffeine. It is the first wearable device that monitors cardiovascular signals and multiple biochemical levels in the human body at the same time.

"This type of wearable would be very helpful for people with underlying medical conditions to monitor their own health on a regular basis," said Lu Yin, a nanoengineering Ph.D. student at UC San Diego and co-first author of the study published Feb. 15 in Nature Biomedical Engineering. "It would also serve as a great tool for remote patient monitoring, especially during the COVID-19 pandemic when people are minimizing in-person visits to the clinic."

Such a device could benefit individuals managing high blood pressure and diabetes--individuals who are also at high risk of becoming seriously ill with COVID-19. It could also be used to detect the onset of sepsis, which is characterized by a sudden drop in blood pressure accompanied by a rapid rise in lactate level.

One soft skin patch that can do it all would also offer a convenient alternative for patients in intensive care units, including infants in the NICU, who need continuous monitoring of blood pressure and other vital signs. These procedures currently involve inserting catheters deep inside patients' arteries and tethering patients to multiple hospital monitors.

"The novelty here is that we take completely different sensors and merge them together on a single small platform as small as a stamp," said Joseph Wang, a professor of nanoengineering at UC San Diego and co-corresponding author of the study. "We can collect so much information with this one wearable and do so in a non-invasive way, without causing discomfort or interruptions to daily activity."

The new patch is a product of two pioneering efforts in the UC San Diego Center for Wearable Sensors, for which Wang serves as director. Wang's lab has been developing wearables capable of monitoring multiple signals simultaneously--chemical, physical and electrophysiological--in the body. And in the lab of UC San Diego nanoengineering professor Sheng Xu, researchers have been developing soft, stretchy electronic skin patches that can monitor blood pressure deep inside the body. By joining forces, the researchers created the first flexible, stretchable wearable device that combines chemical sensing (glucose, lactate, alcohol and caffeine) with blood pressure monitoring.

"Each sensor provides a separate picture of a physical or chemical change. Integrating them all in one wearable patch allows us to stitch those different pictures together to get a more comprehensive overview of what's going on in our bodies," said Xu, who is also a co-corresponding author of the study.

Patch of all trades

The patch is a thin sheet of stretchy polymers that can conform to the skin. It is equipped with a blood pressure sensor and two chemical sensors--one that measures levels of lactate (a biomarker of physical exertion), caffeine and alcohol in sweat, and another that measures glucose levels in interstitial fluid.

The patch is capable of measuring three parameters at once, one from each sensor: blood pressure, glucose, and either lactate, alcohol or caffeine. "Theoretically, we can detect all of them at the same time, but that would require a different sensor design," said Yin, who is also a Ph.D. student in Wang's lab.

The blood pressure sensor sits near the center of the patch. It consists of a set of small ultrasound transducers that are welded to the patch by a conductive ink. A voltage applied to the transducers causes them to send ultrasound waves into the body. When the ultrasound waves bounce off an artery, the sensor detects the echoes and translates the signals into a blood pressure reading.

The chemical sensors are two electrodes that are screen printed on the patch from conductive ink. The electrode that senses lactate, caffeine and alcohol is printed on the right side of the patch; it works by releasing a drug called pilocarpine into the skin to induce sweat and detecting the chemical substances in the sweat. The other electrode, which senses glucose, is printed on the left side; it works by passing a mild electrical current through the skin to release interstitial fluid and measuring the glucose in that fluid.

The researchers were interested in measuring these particular biomarkers because they impact blood pressure. "We chose parameters that would give us a more accurate, more reliable blood pressure measurement," said co-first author Juliane Sempionatto, a nanoengineering Ph.D. student in Wang's lab.

"Let's say you are monitoring your blood pressure, and you see spikes during the day and think that something is wrong. But a biomarker reading could tell you if those spikes were due to an intake of alcohol or caffeine. This combination of sensors can give you that type of information," she said.

In tests, subjects wore the patch on the neck while performing various combinations of the following tasks: exercising on a stationary bicycle; eating a high-sugar meal; drinking an alcoholic beverage; and drinking a caffeinated beverage. Measurements from the patch closely matched those collected by commercial monitoring devices such as a blood pressure cuff, blood lactate meter, glucometer and breathalyzer. Measurements of the wearers' caffeine levels were verified with measurements of sweat samples in the lab spiked with caffeine.

Engineering challenges

One of the biggest challenges in making the patch was eliminating interference between the sensors' signals. To do this, the researchers had to figure out the optimal spacing between the blood pressure sensor and the chemical sensors. They found that one centimeter of spacing did the trick while keeping the device as small as possible.

The researchers also had to figure out how to physically shield the chemical sensors from the blood pressure sensor. The latter normally comes equipped with a liquid ultrasound gel in order to produce clear readings. But the chemical sensors are also equipped with their own hydrogels, and the problem is that if any liquid gel from the blood pressure sensor flows out and makes contact with the other gels, it will cause interference between the sensors. So instead, the researchers used a solid ultrasound gel, which they found works as well as the liquid version but without the leakage.

"Finding the right materials, optimizing the overall layout, integrating the different electronics together in a seamless fashion--these challenges took a lot of time to overcome," said co-first author Muyang Lin, a nanoengineering Ph.D. student in Xu's lab. "We are fortunate to have this great collaboration between our lab and Professor Wang's lab. It has been so fun working together with them on this project."

Next steps

The team is already at work on a new version of the patch, one with even more sensors. "There are opportunities to monitor other biomarkers associated with various diseases. We are looking to add more clinical value to this device," Sempionatto said.

Ongoing work also includes shrinking the electronics for the blood pressure sensor. Right now, the sensor needs to be connected to a power source and a benchtop machine to display its readings. The ultimate goal is to put these all on the patch and make everything wireless.

"We want to make a complete system that is fully wearable," Lin said.

Credit: 
University of California - San Diego

Existing heart failure drug may treat potential COVID-19 long-hauler symptom

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS. This complex, debilitating disorder affects the body's autonomic nervous system, causing a high heart rate, usually when standing.

Writing in the February 15, 2021 online issue of the Journal of the American College of Cardiology, study authors investigated the drug ivabradine and its effects on heart rate, quality of life and plasma norepinephrine levels in persons living with POTS. Norepinephrine is a stress hormone and neurotransmitter. In blood plasma, it is used as a measure of sympathetic nervous system activity. Trial participants experienced a reduction in heart rate, improvement in their symptoms and overall quality of life one month after taking the drug.

"Ivabradine is a novel agent that's FDA-approved for heart failure, but based on its mechanism we thought it could be helpful for patients with POTS as it reduces heart rate without impacting blood pressure," said Pam Taub, MD, cardiologist at the Cardiovascular Institute at UC San Diego Health and associate professor of medicine at UC San Diego School of Medicine. "When we can lower the heart rate, we're providing these patients with the ability to stand up, something they couldn't do without difficulty before due to their POTS diagnosis."

The study involved 22 individuals whose average age was 32 years. Each participant had been screened and recruited from cardiology clinics at UC San Diego Health from 2018 to 2020.

The study utilized a randomized, double-blinded, placebo-controlled crossover design in which patients started on either ivabradine or a placebo for one month. At the end of the month, all participants underwent a washout period where neither drug nor placebo was taken for one week. After the washout period, the participants who had previously received ivabradine switched to placebo and vice versa for one month.

Over the course of the two months, patients also met with researchers for seven different clinic visits in which plasma norepinephrine levels were measured and head-up tilt testing conducted to observe the patient's heart rate when sitting, lying down or standing up.

"Before the study, these patients would be living with elevated heart rates ranging between 100 to 115 beats per minute when standing," said Taub. "After taking ivabradine twice a day for one month, the standing heart rate decreased significantly to around 77 beats per minute compared to the placebo group. Participants also reported improvement in quality of life measures when on the drug."

The researchers also noted ivabradine was well-tolerated with no significant side effects while other drugs used to lower heart rate, such as beta blockers, can cause fatigue and decreased blood pressure.

Taub said the study was the first randomized clinical trial using ivabradine to treat POTS.

POTS is typically caused by a viral infection, trauma, surgery or enforced bedrest, and most commonly affects young women who are either athletes or highly active. Currently, there is no FDA-approved treatment for POTS and the condition can severely impact quality of life. Other symptoms of POTS include "brain fog," lightheadedness, palpitations, tremors, weakness, blurry vision and fatigue.

Recently, POTS has been identified as a potential "long-hauler" symptom of COVID-19.

"In our contemporary practice, we are seeing patients who have previously been infected with COVID-19 present with symptoms consistent with POTS," said Jonathan Hsu, MD, cardiologist at UC San Diego Health. "Given the similarities, this study leads to the question whether therapy with ivabradine may help patients who experience similar symptoms after a COVID-19 infection, and provide an important area for future study as well."

The authors said they hope ivabradine will be considered as a possible treatment option for those with a confirmed diagnosed of POTS. Currently, the drug is not FDA-approved for the disease and when used clinically it would be "off-label" use.

"Similar to patients with COVID-19, patients with POTS need to be followed carefully," said Taub. "Treatment for POTS needs to be personalized for each individual and with this drug, paired with lifestyle therapy, including exercises specific for POTS, we hope we will see more individuals overcome this unfortunate condition."

Credit: 
University of California - San Diego

Tropical paper wasps babysit for neighbours

image: Polistes colonies offer windows into the evolution of cooperation

Image: 
P Kennedy

[Images and video available: see notes to editors]

Wasps provide crucial support to their extended families by babysitting at neighbouring nests, according to new research by a team of biologists from the universities of Bristol, Exeter and UCL published today [15 February] in Nature Ecology and Evolution.

The findings suggest that animals should often seek to help more distant relatives if their closest kin are less in need.

Dr Patrick Kennedy, lead author and Marie Curie research fellow in the School of Biological Sciences at the University of Bristol, said: "These wasps can act like rich family members lending a hand to their second cousins. If there's not much more you can do to help your immediate family, you can turn your attention to the extended family."

By closely observing twenty thousand baby wasps and their carers on colonies around the Panama Canal, the research team could determine the usefulness of workers on colonies of different sizes. They showed that workers become less useful as the number of colony members rises, due to a surplus of help.

Andy Radford, Professor of Behavioural Ecology, also from Bristol and co-author, explained: "By helping more distant relatives who are more in need--those living next door with fewer carers--workers can pass on more copies of their genes overall. We believe that similar principles of diminishing returns might explain seemingly paradoxical acts of altruism in many other social animals."

Dr Kennedy added: "The fact that these paper wasps in Central and South America help at other colonies is really bizarre when you consider that most wasps, ants and bees are extremely hostile to outsiders. To solve this puzzling behaviour, we combined mathematical modelling with our detailed field observations."

Dr Kennedy continued: "We ended up being stung a lot. But it was worth it, because our results show that worker wasps can become redundant at home. A wasp on a colony with few larvae but lots of other workers becomes almost useless: the best thing to do is to babysit the larvae of other relatives."

Since Darwin, biologists have been trying to understand how 'altruism' evolves in animals. At first glance, acts of selflessness to help other individuals do not seem to allow individuals to pass on their genes.

Professor Radford said: "In 1964, the legendary biologist W. D. Hamilton figured out the cardinal rule of animal altruism. Lavish help on your family because they share many of your genes. Copies of your genes will triumph in the population."

But the tropical paper wasps studied by the team baffled Hamilton back in 1964. In Brazil, he was surprised to notice that Polistes wasps were leaving their close family on their home nests and flying off to help the neighbours, who are less closely related.

Previous work by co-author Seirian '@WaspWoman' Sumner, Professor of Behavioural Ecology at University College London, showed that over half the workers in a Panamanian population were helping on multiple nests. Wasps usually viciously attack outsiders, so this babysitting suggested something unusual was going on.

Professor Sumner explained: "Wasps offer amazing windows into the evolution of selflessness. There is so much going on in a wasp nest: power struggles, self-sacrifice, groups battling against the odds to survive... If we want to understand how societies evolve, we should look more deeply at wasps."

Credit: 
University of Bristol

Avian insights into human ciliopathies

image: Surface-rendered whole-mount chick mandibular prominence in wild type chick embryos, stained in blue for DAPI and in red for Sox9, an osteochondroprogenitor marker.

Image: 
Christian Louis Bonatto Paese, Evan C. Brooks, Megan Aarnio-Peterson, Samantha A. Brugmann.

Ciliopathies are genetic disorders caused by defects in the structure and function of cilia, microtubule-based organelles present on the surface of almost every cell in the human body which play crucial roles in cell signalling. Ciliopathies present a wide range of often severe clinical symptoms, frequently affecting the head and face and leading to conditions such as cleft palate and micrognathia (an underdeveloped lower jaw that can impair feeding and breathing). While we understand many of the genetic causes of human ciliopathies, they are only half the story: the question remains as to why, at a cellular level, defective cilia cause developmental craniofacial abnormalities. Researchers have now discovered that ciliopathic micrognathia in an animal model results from abnormal skeletal differentiation and remodelling. The work from Christian Bonatto Paese, Evan Brooks and others from Samantha Brugmann's lab at the Cincinnati Children's Hospital Medical Center in the USA is published in the journal Development.

The researchers used the avian ta2 mutant as a model for Oral-Facial-Digital syndrome subtype 14 (OFD14), a rare human ciliopathy characterised by micrognathia. They observed defective formation of the jaw bone (mandible) at early stages of development in ta2 mutants. These defects correlated with unchecked progression through the cell cycle and over-proliferation in skeletal progenitor cells. Importantly, these progenitor cells failed to differentiate into mature osteoblasts (the cells that secrete bone), and this failure of differentiation subsequently led to a reduction in bone deposition and hence micrognathia. The researchers also identified excessive bone resorption, a process which normally contributes to final size and shape of the mandible, as an additional causative factor in the ta2 micrognathia. This work informs our understanding of the etiology of human ciliopathic micrognathia.

"We have identified distinct cellular processes that are impaired during the onset of ciliopathic micrognathia," says Samantha Brugmann. "We know from previous work that these processes are responsive to treatment with pharmacological agents, and we are currently testing a number of these agents to determine if 'rescuing' ciliopathic micrognathia is possible. The therapeutic implications are exceptionally real."

"We are also currently trying to uncover how various organ systems respond to loss of cilia and which molecular and signalling pathways are affected, to continue to advance our understanding of how to tackle treatment for patients," says Christian Bonatto Paese.

The paper exemplifies how developmental biology can shine a light on devastating genetic disorders. Brugmann concludes: "The most important impact of this study, to me, is how useful basic science and the avian embryo can be towards uncovering mechanisms for human disease."

Credit: 
The Company of Biologists

Strange creatures accidentally discovered beneath Antarctica's ice shelves

image: British Antarctic Survey camera travelling down the 900-meter-long bore hole in the Filchner-Ronne Ice Shelf. (Marine creature pictured is unrelated to the discovery)

Image: 
Dr Huw Griffiths/British Antarctic Survey

Far underneath the ice shelves of the Antarctic, there's more life than expected, finds a recent study in the journal Frontiers in Marine Science.

During an exploratory survey, researchers drilled through 900 meters of ice in the Filchner-Ronne Ice Shelf, situated on the south eastern Weddell Sea. At a distance of 260km away from the open ocean, under complete darkness and with temperatures of -2.2°C, very few animals have ever been observed in these conditions.

But this study is the first to discover the existence of stationary animals - similar to sponges and potentially several previously unknown species - attached to a boulder on the sea floor.

"This discovery is one of those fortunate accidents that pushes ideas in a different direction and shows us that Antarctic marine life is incredibly special and amazingly adapted to a frozen world," says biogeographer and lead author, Dr Huw Griffiths of British Antarctic Survey.

More questions than answers

"Our discovery raises so many more questions than it answers, such as how did they get there? What are they eating? How long have they been there? How common are these boulders covered in life? Are these the same species as we see outside the ice shelf or are they new species? And what would happen to these communities if the ice shelf collapsed?"

Floating ice shelves represent the greatest unexplored habitat in the Southern Ocean. They cover more that 1.5m sq km of the Antarctic continental shelf, but only a total area similar in size to a tennis court has been studied through eight prior boreholes.

Current theories on what life could survive under ice shelves suggest that all life becomes less abundant as you move further away from open water and sunlight. Past studies have found some small mobile scavengers and predators, such as fish, worms, jellyfish or krill, in these habitats. But filter feeding organisms - which depend on a supply of food from above - were expected to be amongst the first to disappear further under the ice.

So, it came as a surprise when the team of geologists, drilling through the ice to collect sediment samples, hit a rock instead of mud at the bottom of the ocean below. They were even more surprised by the video footage, which showed a large boulder covered in strange creatures.

New Antarctic expedition needed

This is the first ever record of a hard substrate (ie a boulder) community deep beneath an ice shelf and it appears to go against all previous theories of what types of life could survive there.

Given the water currents in the region, the researchers calculate that this community may be as much as 1,500km upstream from the closest source of photosynthesis. Other organisms are also known to collect nutrients from glacial melts or chemicals from methane seeps, but the researchers won't know more about these organisms until they have the tools to collect samples of these organisms--a significant challenge in itself.

"To answer our questions we will have to find a way of getting up close with these animals and their environment - and that's under 900 meters of ice, 260km away from the ships where our labs are," continues Griffiths. "This means that as polar scientists, we are going to have to find new and innovative ways to study them and answer all the new questions we have."

Griffiths and the team also note that with the climate crisis and the collapse of these ice shelves, time is running out to study and protect these ecosystems.

Credit: 
Frontiers

Neanderthals and Homo sapiens used identical Nubian technology

image: The view from Shukbah Cave

Image: 
Amos Frumkin

Long held in a private collection, the newly analysed tooth of an approximately 9-year-old Neanderthal child marks the hominin's southernmost known range. Analysis of the associated archaeological assemblage suggests Neanderthals used Nubian Levallois technology, previously thought to be restricted to Homo sapiens.

With a high concentration of cave sites harbouring evidence of past populations and their behaviour, the Levant is a major centre for human origins research. For over a century, archaeological excavations in the Levant have produced human fossils and stone tool assemblages that reveal landscapes inhabited by both Neanderthals and Homo sapiens, making this region a potential mixing ground between populations. Distinguishing these populations by stone tool assemblages alone is difficult, but one technology, the distinct Nubian Levallois method, is argued to have been produced only by Homo sapiens.

In a new study published in Scientific Reports, researchers from the Max Planck Institute for the Science of Human History teamed up with international partners to re-examine the fossil and archaeological record of Shukbah Cave. Their findings extend the southernmost known range of Neanderthals and suggest that our now-extinct relatives made use of a technology previously argued to be a trademark of modern humans. This study marks the first time the lone human tooth from the site has been studied in detail, in combination with a major comparative study examining the stone tool assemblage.

"Sites where hominin fossils are directly associated with stone tool assemblages remain a rarity - but the study of both fossils and tools is critical for understanding hominin occupations of Shukbah Cave and the larger region," says lead author Dr Jimbob Blinkhorn, formerly of Royal Holloway, University of London and now with the Pan-African Evolution Research Group (Max Planck Institute for the Science of Human History).

Shukbah Cave was first excavated in the spring of 1928 by Dorothy Garrod, who reported a rich assemblage of animal bones and Mousterian-style stone tools cemented in breccia deposits, often concentrated in well-marked hearths. She also identified a large, unique human molar. However, the specimen was kept in a private collection for most of the 20th century, prohibiting comparative studies using modern methods. The recent re-identification of the tooth at the Natural History Museum in London has led to new detailed work on the Shukbah collections.

"Professor Garrod immediately saw how distinctive this tooth was. We've examined the size, shape and both the external and internal 3D structure of the tooth, and compared that to Holocene and Pleistocene Homo sapiens and Neanderthal specimens. This has enabled us to clearly characterise the tooth as belonging to an approximately 9 year old Neanderthal child," says Dr. Clément Zanolli, from Université de Bordeaux. "Shukbah marks the southernmost extent of the Neanderthal range known to date," adds Zanolli.

Although Homo sapiens and Neanderthals shared the use of a wide suite of stone tool technologies, Nubian Levallois technology has recently been argued to have been exclusively used by Homo sapiens. The argument has been made particularly in southwest Asia, where Nubian Levallois tools have been used to track human dispersals in the absence of fossils.

"Illustrations of the stone tool collections from Shukbah hinted at the presence of Nubian Levallois technology so we revisited the collections to investigate further. In the end, we identified many more artefacts produced using the Nubian Levallois methods than we had anticipated," says Blinkhorn. "This is the first time they've been found in direct association with Neanderthal fossils, which suggests we can't make a simple link between this technology and Homo sapiens."

"Southwest Asia is a dynamic region in terms of hominin demography, behaviour and environmental change, and may be particularly important to examine interactions between Neanderthals and Homo sapiens," adds Prof Simon Blockley, of Royal Holloway, University of London. "This study highlights the geographic range of Neanderthal populations and their behavioural flexibility, but also issues a timely note of caution that there are no straightforward links between particular hominins and specific stone tool technologies."

"Up to now we have no direct evidence of a Neanderthal presence in Africa," said Prof Chris Stringer of the Natural History Museum. "But the southerly location of Shukbah, only about 400 km from Cairo, should remind us that they may have even dispersed into Africa at times."

Credit: 
Max Planck Institute of Geoanthropology

The comet that killed the dinosaurs

image: A comet plunging through Earth's atmosphere.

Image: 
Gerd Altmann/Pixabay

It was tens of miles wide and forever changed history when it crashed into Earth about 66 million years ago.

The Chicxulub impactor, as it's known, left behind a crater off the coast of Mexico that spans 93 miles and goes 12 miles deep. Its devastating impact brought the reign of the dinosaurs to an abrupt and calamitous end by triggering their sudden mass extinction, along with the end of almost three-quarters of the plant and animal species then living on Earth.

The enduring puzzle has always been where the asteroid or comet that set off the destruction originated, and how it came to strike the Earth. And now a pair of Harvard researchers believe they have the answer.

In a study published in Scientific Reports, Avi Loeb, Frank B. Baird Jr. Professor of Science at Harvard, and Amir Siraj '21, an astrophysics concentrator, put forth a new theory that could explain the origin and journey of this catastrophic object and others like it.

Using statistical analysis and gravitational simulations, Loeb and Siraj show that a significant fraction of a type of comet originating from the Oort cloud, a sphere of debris at the edge of the solar system, was bumped off-course by Jupiter's gravitational field during its orbit and sent close to the sun, whose tidal force broke apart pieces of the rock. That increases the rate of comets like Chicxulub (pronounced Chicks-uh-lub) because these fragments cross the Earth's orbit and hit the planet once every 250 to 730 million years or so.

"Basically, Jupiter acts as a kind of pinball machine," said Siraj, who is also co-president of Harvard Students for the Exploration and Development of Space and is pursuing a master's degree at the New England Conservatory of Music. "Jupiter kicks these incoming long-period comets into orbits that bring them very close to the sun."

It's because of this that long-period comets, which take more than 200 years to orbit the sun, are called sun grazers, he said.

"When you have these sun grazers, it's not so much the melting that goes on, which is a pretty small fraction relative to the total mass, but the comet is so close to the sun that the part that's closer to the sun feels a stronger gravitational pull than the part that is farther from the sun, causing a tidal force" he said. "You get what's called a tidal disruption event and so these large comets that come really close to the sun break up into smaller comets. And basically, on their way out, there's a statistical chance that these smaller comets hit the Earth."

The calculations from Loeb and Siraj's theory increase the chances of long-period comets impacting Earth by a factor of about 10, and show that about 20 percent of long-period comets become sun grazers. That finding falls in line with research from other astronomers.

The pair claim that their new rate of impact is consistent with the age of Chicxulub, providing a satisfactory explanation for its origin and other impactors like it.

"Our paper provides a basis for explaining the occurrence of this event," Loeb said. "We are suggesting that, in fact, if you break up an object as it comes close to the sun, it could give rise to the appropriate event rate and also the kind of impact that killed the dinosaurs."

Loeb and Siraj's hypothesis might also explain the makeup of many of these impactors.

"Our hypothesis predicts that other Chicxulub-size craters on Earth are more likely to correspond to an impactor with a primitive (carbonaceous chondrite) composition than expected from the conventional main-belt asteroids," the researchers wrote in the paper.

This is important because a popular theory on the origin of Chicxulub claims the impactor is a fragment of a much larger asteroid that came from the main belt, which is an asteroid population between the orbit of Jupiter and Mars. Only about a tenth of all main-belt asteroids have a composition of carbonaceous chondrite, while it's assumed most long-period comets have it. Evidence found at the Chicxulub crater and other similar craters that suggests they had carbonaceous chondrite.

This includes an object that hit about 2 billion years ago and left the Vredefort crater in South Africa, which is the largest confirmed crater in Earth's history, and the impactor that left the Zhamanshin crater in Kazakhstan, which is the largest confirmed crater within the last million years.

The researchers say that composition evidence supports their model and that the years the objects hit support both their calculations on impact rates of Chicxulub-sized tidally disrupted comets and for smaller ones like the impactor that made the Zhamanshin crater. If produced the same way, they say those would strike Earth once every 250,000 to 730,000 years.

Loeb and Siraj say their hypothesis can be tested by further studying these craters, others like them, and even ones on the surface of the moon to determine the composition of the impactors. Space missions sampling comets can also help.

Aside from composition of comets, the new Vera Rubin Observatory in Chile may be able to see the tidal disruption of long-period comets after it becomes operational next year.

"We should see smaller fragments coming to Earth more frequently from the Oort cloud," Loeb said. "I hope that we can test the theory by having more data on long-period comets, get better statistics, and perhaps see evidence for some fragments."

Loeb said understanding this is not just crucial to solving a mystery of Earth's history but could prove pivotal if such an event were to threaten the planet again.

"It must have been an amazing sight, but we don't want to see that side," he said.

Credit: 
Harvard University

Membrane building blocks play decisive role in controlling cell growth

image: A pollen tube that grows out of a polen grain with certain fluorescently labelled building blocks. In green: PIP5K2 , the enzyme responsible for the production of lipid nano domains in the cell membrane. In magenta: actin cytoskeleton (cell "bones"), which is regulated by the lipid nanodomains.

Image: 
Marta Fratini

Lipids are the building blocks of a cell's envelope - the cell membrane. In addition to their structural function, some lipids also play a regulatory role and decisively influence cell growth. This has been investigated in a new study by scientists at Martin Luther University Halle-Wittenberg (MLU). The impact of the lipids depends on how they are distributed over the plasma membrane. The study was published in "The Plant Cell".

If plant cells want to move, they need to grow. One notable example of this is the pollen tube. When pollen lands on a flower, the pollen tube grows directionally into the female reproductive organs. This allows the male gametes to be delivered, so fertilisation can occur. The pollen tube is special in that it is made up of a single cell that continues to extend and, in extreme cases, can become several centimetres long. "This makes pollen tubes an exciting object for research on directional growth processes," says Professor Ingo Heilmann, head of the Department of Plant Biochemistry at MLU.

For the current study, Heilmann's team focused on the phospholipids of pollen tubes, which, as the main component of the plasma membrane, are responsible for separating the cell's interior from its surroundings. "Lipids are generally known to have this structuring function," says Dr Marta Fratini, first author of the study. It has only recently come to light that some phospholipids can also regulate cellular processes. The scientists from Halle have now been able to show that a specific phospholipid called phosphatidylinositol 4,5-bisphosphate ("PIP2") can control various aspects of cell growth in pollen tubes - depending on its position at the plasma membrane. They did this by labelling the lipid with a fluorescent marker. "We found it is either distributed diffusely over the entire tip of the pollen tube without a recognisable pattern, or is concentrated in small dynamic nanodomains," Fratini explains. One can imagine a group of people on a square: either individuals remain 1.5 metres apart as currently prescribed, or they form small groups.

It appears that different enzymes are responsible for the varying distribution of PIP2. "Plant cells have several enzymes that can produce this one phospholipid," explains Heilmann. Like the lipids, some of these enzymes are widely distributed over the membrane and others are concentrated in nanodomains, as shown by the current study. Depending on which of the enzymes the researchers artificially increased, either the cytoskeleton - a structure important for directed growth - stabilised and the pollen tube swelled at the tip, or more pectin - an important building material for plant cell walls - was secreted. This made the cell branch out at the tip. To make sure that the distribution of the lipids was indeed responsible for these growth effects, the biochemists artificially changed the arrangement of the enzymes at the plasma membrane - from clusters to a wide scattering or vice versa. It turns out they were able to control the respective effects on cell growth.

"As far as I know, our study is the first to trace the regulatory function of a lipid back to its spatial distribution in the membrane," says Heilmann. Further research is now needed to clarify exactly how the membrane nanodomains assemble and how the distribution of PIP2 at the membrane can have such varying effects.

Credit: 
Martin-Luther-Universität Halle-Wittenberg

Commuters are inhaling unacceptably high levels of carcinogens

image: Driver exercising extreme caution in his car.

Image: 
Stan Lim/UCR

A new study finds that California's commuters are likely inhaling chemicals at levels that increase the risk for cancer and birth defects.

As with most chemicals, the poison is in the amount. Under a certain threshold of exposure, even known carcinogens are not likely to cause cancer. Once you cross that threshold, the risk for disease increases.

Governmental agencies tend to regulate that threshold in workplaces. However, private spaces such as the interior of our cars and living rooms are less studied and less regulated.

Benzene and formaldehyde -- both used in automobile manufacturing -- are known to cause cancer at or above certain levels of exposure and are Prop. 65-listed chemicals.

New UC Riverside research shows that the average commuter in California is exceeding the threshold for exposure, breathing in unsustainably high levels of both chemicals.

Both benzene and formaldehyde are carcinogens, and benzene carries the additional risk of reproductive and developmental toxicity.

"These chemicals are very volatile, moving easily from plastics and textiles to the air that you breathe," said David Volz, UCR professor of environmental toxicology.

The study, published in the journal Environment International, calculated the daily dose of benzene and formaldehyde being inhaled by drivers with commutes of at least 20 minutes per day.

It found that up to 90% of the population in Los Angeles, San Diego, Orange, Santa Clara, and Alameda counties have at least a 10% chance of exceeding cancer risk from inhaling the chemicals, based on having 30-minute average commute times.

"Of course, there is a range of exposure that depends on how long you're in the car, and how much of the compounds your car is emitting," said Aalekhya Reddam, a graduate student in the Volz laboratory, and lead author of the study.

Previously, Volz and Reddam studied commuter exposure to a flame retardant called TDCIPP or chlorinated tris, and found that longer commute times increased exposure to that carcinogen as well.

They set out on this study wanting to understand the risk of that compound relative to other chemicals introduced during car manufacturing.

Reddam advises commuters to keep the windows open during their rides if possible. "At least with some air flow, you'd be diluting the concentration of these chemicals inside your car," she said.

Benzene is used to produce synthetic fibers, and formaldehyde is a binder in plastics. "There should be alternatives to these chemicals to achieve the same goals during vehicle manufacturing," Volz said. "If so, these should be used."

Credit: 
University of California - Riverside

Clues for improving sleep in visually impaired athletes

Tsukuba, Japan - Sleep is very important for athletes, and sleep loss can affect physical performance and cognitive ability. But now, researchers from the University of Tsukuba have identified the prevalence of sleep disorders in visually impaired athletes, as well as specific risk factors associated with lower sleep quality.

In a study published last November in Sleep Medicine, researchers from the University of Tsukuba conducted a survey of 99 visually impaired athletes in Japan and analyzed data from 81 respondents. They found that approximately one-third of the respondents had sleep disorders. Further, higher levels of stress regarding interpersonal relationships in competition activities and a later wake-up time were associated with the rate of sleep disorders.

As sleep disorders are known to be especially common in visually impaired individuals, athletes who are visually impaired may be especially at risk. However, the factors associated with sleep quality in visually impaired athletes are unknown. Therefore, the researchers at the University of Tsukuba aimed to address this in their study.

To examine the prevalence and risk factors associated with sleep disorders in visually impaired athletes, the researchers collected data regarding the severity of vision loss, sleep quality, lifestyle habits, competition activities, and psychological distress in visually impaired athletes who were active in Paralympic sports events in Japan, such as marathon running, goalball, swimming, blind soccer, and judo.

"Our data indicated that roughly a third of the study participants had sleep disorders," explains Professor Takeda. "This prevalence was similar to that found in sighted athletes, including other para-athletes."

"Our analysis revealed that stress associated with interpersonal relationships in competition activities was independently related to sleep disorders in the study participants," explains Professor Takeda, "as was a late wake-up time."

Given that interpersonal stressors arising from competition activities were associated with sleep disorders, new strategies for improving these relationships could help improve sleep quality in visually impaired athletes. Further, strategies to help athletes adjust their wake-up time may have a positive effect on sleep quality.

Credit: 
University of Tsukuba

Research highlights ways to protect astronaut cardiovascular health from space radiation

Space: the final frontier. What's stopping us from exploring it? Well, lots of things, but one of the major issues is space radiation, and the effects it can have on astronaut health during long voyages. A new review in the open-access journal Frontiers in Cardiovascular Medicine explores what we know about the ways that space radiation can negatively affect cardiovascular health, and discusses methods to protect astronauts. These include radioprotective drugs, and antioxidant treatments, some of which are more common than you might think.

Space is incredibly inhospitable. Outside of low earth orbit, astronauts are bombarded with radiation, including galactic cosmic rays, and 'proton storms' released by the sun. This radiation is harmful for the human body, damaging proteins and DNA, and is one of the major reasons that we haven't yet been able to send anyone to Mars, or beyond.

These issues inspired Dr Jesper Hjortnaes of the Leiden University Medical Center in the Netherlands to investigate what we know about the harmful effects of space radiation. "If we want to see human long distance space travel, we need to understand the impact of space-induced disease and how to protect our bodies from it," said Hjortnaes. However, Hjortnaes has an interest in a specific aspect of space radiation: its cardiovascular effects.

You may be surprised to learn that aside from the illnesses we typically associate with radiation, such as cancer, it can also have serious effects on the cardiovascular system. Suffering from cardiovascular illness would be catastrophic for crew members on long-haul space missions, and so it's important to identify what the risks are, and how to reduce them.

Hjortnaes and colleagues reviewed the evidence to establish what we know about the cardiovascular risks of space radiation. Much of what we know comes from studying people who have received radiation therapy for cancer, where cardiovascular disease is a common side-effect, or from mouse studies of radiation exposure.

So, what are the effects? Radiation can cause myocardial remodeling, where the structure of the heart begins to change, and tough, fibrous tissue grows to replace healthy muscle, potentially leading to heart failure. Other effects include atherosclerosis in blood vessels, which can cause stroke or heart attack. Radiation exerts its effects by causing inflammation, oxidative stress, cell death and DNA damage.

Researchers have also investigated potential ways to protect astronauts. These include drugs that an astronaut could take to protect themselves from space radiation, and antioxidants. Interestingly, an antioxidant diet, including dairy products, green vegetables such as spinach, and antioxidant supplements such as vitamin C, has potential in protecting astronauts from the damaging reactive oxygen molecules produced during radiation exposure.

Overall, the review revealed that so far, research has only scratched the surface of space radiation and the best methods to protect astronauts from it. There is little conclusive evidence of radiation-induced cardiovascular disease in astronauts themselves, as so few of them have ever gone further than low earth orbit, and mouse studies aren't an exact match for humans.

These issues prompted Hjortnaes and colleagues, who develop human cardiac tissue in the laboratory, to conclude that we need further research into these issues, and new research methods, such as organ-on-a-chip testing technologies.

"We need to develop human-based tissue platforms, such as heart-on-a-chip systems, that can simulate real human disease, outside of the human body, to unravel the mechanisms at play in space radiation-induced cardiovascular disease," said Hjortnaes.

Credit: 
Frontiers

Disease epidemic possibly caused population collapse in Central Africa 1600-1400 years ago

A new study published in the journal Science Advances shows that Bantu-speaking communities in the Congo rainforest underwent a major population collapse from 1600 to 1400 years ago, probably due to a prolonged disease epidemic, and that significant resettlement did not restart until around 1000 years ago. These findings revise the population history of no less than seven present-day African countries (Cameroon, Central African Republic, Democratic Republic of the Congo, Republic of the Congo, Gabon, Equatorial Guinea, and Angola) and challenges the commonly held belief that the settlement of Central Africa by Bantu-speaking communities was a continuous process from about 4000 years ago until the start of the transatlantic slave trade.

Ongoing debates about decolonization, restitution of African cultural heritage and antiracism have also renewed interest in the European colonization of Central Africa, even if it was a relatively short period in the long and eventful history of the region. Modern humans lived in the savannas of Central Africa several tens of thousands of years before they emerged in Europe. Also, in the Congo rainforest did our ancestors overcome many challenges long before the first European expedition traversed it, as shown again in this recently published study.

Unique interdisciplinary research method

As part of a cross-disciplinary research project examining the interconnections between human migration, language spread, climate change and early farming in pre-colonial Central Africa, the current study combines a comprehensive analysis of all available archeological radiocarbon dates as a proxy for human activity and demographic fluctuation with a comprehensive analysis of the diversity and distribution of pottery styles as a proxy for socio-economic development. These well-dated archeological records were further compared in this study with genetic and linguistic evidence to gain new insights into the ancient settlement history of Bantu-speaking populations in the Congo rainforest.

According to archeologist Dirk Seidensticker (UGent), one of the two lead authors, the multi-proxy approach developed in this study is unique both in terms of empirical evidence and scientific method, in that it uses 1149 radiocarbon dates linked to 115 pottery styles recovered from 726 sites throughout the Congo rainforest and adjacent areas: "We are the first to integrate these three types of archeological datasets on such a large scale and for such a long period and to demonstrate that throughout Central Africa two periods of more intense human activity (~800 BCE to 400 CE and ~1000 to 1900 CE) are separated by a widespread population collapse between 400 and 600 CE. Doing so, we could clearly delineate the periods commonly known as the Early Iron Age and Late Iron Age, each of them characterized by distinct pottery styles which first underwent a widespread expansion phase followed by a regionalization phase with many more local pottery styles. Pottery being one of the few material items of cultural heritage that has survived the ravages of time, this is an important step forward for the archeology of Central Africa."

New insights on the controversial Bantu Expansion

The initial spread of Bantu-speaking people from their homeland on the border between Nigeria and Cameroon towards eastern and southern Africa starting some 4000 years ago is unique in the world due to its magnitude, rapid pace, and adaptation to multiple ecozones. This spread had a momentous impact on the continent's linguistic, demographic, and cultural landscape. The Bantu languages constitute Africa's largest language family: about 1 out of 3 Africans speak one or several Bantu languages.

Historical linguist and Africanist Koen Bostoen (UGent) is excited about how these new insights that urge us to rethink the Bantu Expansion, one of the most controversial issues in African History: "Africa's colonization by Bantu speech communities is usually seen as a single, long-term and continuous macro-event. We tend to see today's Bantu speakers as direct descendants from those who originally settled the rainforest some 2700 years ago. Likewise, we think that current-day Bantu languages developed directly from the ancestral languages of those first settlers. However, our results show that this initial wave of Bantu-speaking Early Iron Age communities had largely vanished from the entire Congo rainforest region by 600 CE. The Bantu languages of this area may thus be almost 1000 years younger than previously thought. Scientifically speaking, this introduces new challenges for our use of linguistic data to reconstruct Africa's history. More generally, our study shows that African societies faced serious catastrophes long before the transatlantic slave trade and European colonization and had the resilience to overcome them. This is hopeful."

A prolonged epidemic as the cause of population collapse?

Paleobotanist and tropical forest ecologist Wannes Hubau (UGent & RMCA Tervuren), the other lead author, highlights that the drastic population collapse around 400-600 CE coincided with wetter climatic conditions across the region and may therefore have been promoted by a prolonged disease epidemic: "We note the broad coincidence between the sharp demographic decline in the Congo rainforest and the Justinian Plague (541-750 CE), which is regarded as one of the factors leading to the fall of both the Roman Empire and the Aksumite Empire in Ethiopia. It may have killed up to 100 million people in Asia, Europe, and Africa. We have no firm evidence that the population collapse observed in our archeological data is really due to a persistent vector-borne disease. However, the bacteria Yersinia pestis, which caused the Justinian Plague, has a long-standing presence in Central Africa. One particular strain, still found today in DRC, Zambia, Kenya and Uganda, has prevailed in Central Africa for at least 300 years and is the oldest living strain closely related to the lineage that caused the Black Death in 14th century Europe. We therefore consider a prolonged pandemic of plague to be a plausible hypothesis for the observed supra-regional population decline in 5th-6th century Central Africa."

Credit: 
Ghent University